SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 424B5
Document Type: 424B5
Date Filed: 2025-12-09
Accession Number: 0001213900-25-119671
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025119671/ea0268926-424b5_synergy.htm

Chunk 17 of 23
Word Count: 1494
Character Count: 9243

Document Content:

the debt securities of all series affected voting as one class. Unless the securities resolution or supplemental indenture otherwise provides (in which event the applicable prospectus supplement will so state), a Default other than a Default in payment on a particular series may be waived with the consent of the holders of a majority in principal amount of the debt securities of the series. However, without the consent of each securityholder affected, no amendment or waiver may: ● change the fixed maturity of or the time for payment of interest on any debt security; ● reduce the principal, premium or interest payable with respect to any debt security; ● change the place of payment of any debt security or the currency in which the principal or interest on a debt security is payable; ● change the provisions for calculating any redemption or repurchase price with respect to any debt security;

●	adversely affect any holder’s right to receive payment of principal and interest or to institute suite for an enforcement of any such payment;

●	reduce the amount of debt securities whose holders must consent to an amendment or waiver;

●	make any change that materially adversely affects the right to convert any debt security;

●	waive any Default in payment of principal of or interest on a debt security; or

●	adversely affect any holder’s rights with respect to redemption or repurchase of a debt.

Without the consent of any
securityholder, the indentures or the debt securities may be amended to:

●	provide for assumption of our obligations to securityholders in the event of a merger or consolidation requiring such assumption;

●	cure any ambiguity, omission, defect or inconsistency;

●	conform the terms of the debt securities to the description thereof in the prospectus and prospectus supplement offering such debt securities;

●	create a series and establish its terms;

●	provide for the acceptance of appointment by a successor trustee or to facilitate the administration of the trusts by more than one trustee;

●	provide for uncertificated or unregistered securities;

●	make any change that does not adversely affect the rights of any securityholder;

●	add to our covenants; or

●	make any other change to the indentures so long as no debt securities are outstanding.

Conversion Rights

Any securities resolution
or supplemental indenture establishing a series of debt securities may provide that the debt securities of such series will be convertible
at the option of the holders thereof into or for our common stock or other equity or debt instruments. The securities resolution or supplemental
indenture may establish, among other things: (1) the number or amount of shares of common stock or other equity or debt instruments for
which $1,000 aggregate principal amount of the debt securities of the series is convertible, as may be adjusted pursuant to the terms
of the relevant indenture and the securities resolution; and (2) provisions for adjustments to the conversion rate and limitations upon
exercise of the conversion right. The indentures provide that we will not be required to make an adjustment in the conversion rate unless
the adjustment would require a cumulative change of at least one percent (1.0)% in the conversion rate. However, we will carry forward
any adjustments that are less than one percent (1.0%) of the conversion rate and take them into account in any subsequent adjustment of
the conversion rate.

Legal Defeasance and Covenant Defeasance

Debt securities of a series
may be defeased in accordance with their terms and, unless the securities resolution or supplemental indenture establishing the terms
of the series otherwise provides, as set forth below. We at any time may terminate as to a series all of our obligations (except for certain
obligations, including obligations with respect to the defeasance trust and obligations to register the transfer or exchange of a debt
security, to replace destroyed, lost or stolen debt securities and coupons and to maintain paying agencies in respect of the debt securities)
with respect to the debt securities of the series and any related coupons and the relevant indenture, which we refer to as legal defeasance.
We at any time may terminate as to a series our obligations with respect to any restrictive covenants which may be applicable to a particular
series, which we refer to as covenant defeasance.

We may exercise our legal
defeasance option notwithstanding our prior exercise of our covenant defeasance option. If we exercise our legal defeasance option, a
series may not be accelerated because of an Event of Default. If we exercise our covenant defeasance option, a series may not be accelerated
by reference to any covenant which may be applicable to a series.

To exercise either defeasance
option as to a series, we must: (1) irrevocably deposit in trust with the trustee (or another trustee) money or U.S. Government Obligations
(as defined below), deliver a certificate from a nationally recognized firm of independent accountants expressing their opinion that the
payments of principal and interest when due on the deposited U.S. Government Obligations, without reinvestment, plus any deposited money
without investment will provide cash at such times and in such amounts as will be sufficient to pay the principal and interest when due
on all debt securities of such series to maturity or redemption, as the case may be; and (2) comply with certain other conditions. In
particular, we must obtain an opinion of tax counsel that the defeasance will not result in recognition of any gain or loss to holders
for federal income tax purposes.

“U.S. Government Obligations”
means direct obligations of the United States or any agency or instrumentality of the United States, the payment of which is unconditionally
guaranteed by the United States, which, in either case, have the full faith and credit of the United States pledged for payment and which
are not callable at the issuer’s option, or certificates representing an ownership interest in such obligations.

Regarding the Trustee

Unless otherwise indicated
in a prospectus supplement, the trustee will also act as depository of funds, transfer agent, paying agent and conversion agent, as applicable,
with respect to the debt securities. In certain circumstances, we or the securityholders may remove the trustee as the trustee under a
given indenture. The indenture trustee may also provide additional unrelated services to us as a depository of funds, registrar, trustee
and similar services.

Governing Law

The indentures and the debt
securities will be governed by New York law, except to the extent that the Trust Indenture Act of 1939 is applicable.

DESCRIPTION OF STOCK WARRANTS

We summarize below some of
the provisions that will apply to the warrants unless the applicable prospectus supplement provides otherwise. This summary may not contain
all information that is important to you. The complete terms of the warrants will be contained in the applicable warrant certificate and
warrant agreement. These documents have been or will be included or incorporated by reference as exhibits to the registration statement
of which this prospectus is a part. You should read the warrant certificate and the warrant agreement. You should also read the prospectus
supplement, which will contain additional information and which may update or change some of the information below.

General

We may issue, together with
common or preferred stock as units or separately, warrants for the purchase of shares of our common or preferred stock. The terms of each
warrant will be discussed in the applicable prospectus supplement relating to the particular series of warrants. The form(s) of certificate
representing the warrants and/or the warrant agreement will be, in each case, filed with the SEC as an exhibit to a document incorporated
by reference in the registration statement of which this prospectus is a part on or prior to the date of any prospectus supplement relating
to an offering of the particular warrant. The following summary of material provisions of the warrants and the warrant agreements are
subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable
to a particular series of warrants.

The prospectus supplement
relating to any series of warrants that are offered by this prospectus will describe, among other things, the following terms to the extent
they are applicable to that series of warrants:

●	the procedures and conditions relating to the exercise of the warrants;

●	the number of shares of our common or preferred stock, if any, issued with the warrants;

●	the date, if any, on and after which the warrants and any related shares of our common or preferred stock will be separately transferable;

●	the offering price of the warrants, if any;

●	the number of shares of our common or preferred stock which may be purchased upon exercise of the warrants and the price or prices at which the shares may be purchased upon exercise;

●	the date on which the right to exercise the warrants will begin and the date on which the right will expire;